• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Nextrials’s new iPad app to offer mobile access to clinical trial data and study metrics

Nextrials’s new iPad app to offer mobile access to clinical trial data and study metrics

June 27, 2012
CenterWatch Staff

Nextrials, a web-based software solutions company for the clinical research industry, announced that its iPad application for Prism, its award-winning clinical trial management platform, will be available toward the end of Q3 2012.  

With the new iPad application, pharmaceutical and biotech researchers will receive anytime/anywhere access to key data points, reports and statistics about ongoing studies. Regardless of location, the new application will enable researchers to view real-time data related to patient recruitment/enrollment status, demographics, queries and monitoring through Prism’s custom-built iPad interface.

"Today’s clinical trials and patient care are so closely intertwined that technology tools such as Prism’s iPad app are valuable from any number of standpoints,” said Robert Barr, chief technology officer, Nextrials. "The Prism iPad app gives sponsors the ability to better manage investigator site data, logistics and costs regardless of user location; and from the healthcare viewpoint, since the iPad’s usage at the bedside is increasing, primary care physicians can use the same device to see applicable patient data immediately through the subject’s permanent health record.”

Nextrials helped write the industry standards for integrating the electronic data capture (EDC) platforms used within clinical trials with the platforms to collect patient data for electronic health records (EHR) in the healthcare setting. As a result, the converged technologies—Prism with its new iPad app and use of the iPad for accessing EHR systems—are powerful tools for researchers and healthcare workers alike, enabling them to improve the efficiency and continuum of patient care.

When it is approved by Apple (estimated to be in late Q3), Nextrials’ Prism iPad application will be available to all enrolled Prism users as a free download, accessible through the iTunes store.

Visitors to the 48th Annual Meeting of the Drug Information Association, held June 24-28 in Philadelphia, can get a sneak peek of the Prism iPad application in the Nextrials booth (#2007).

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • MAGI East 2023

    MAGI East 2023 Preview: Janssen Reports on Environmental Impact of Trials

  • Complexity-360x240.png

    Phase 3 Trials Significantly Rising in Complexity, Says CSDD

  • Quality Level Scale

    Build Quality into Trials Like You’d Build a House, Says FDA’s BIMO Director

  • DE&I

    Trust-Building, Community Connection Still Essential to DE&I Efforts, Experts Say

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing